Inhibitors of advanced glycation end-products (ages)formation
US9387198B1 · kind B1 · utility
1Cited by
0References
3Claims
0Family size
Inventors
Key dates
| Filing date | Feb 27, 2015 |
| Grant date | Jul 12, 2016 |
| Priority date | — |
| Expiry date | Feb 27, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/4184
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to methods of inhibiting the protein glycation process and the associated formation of Advanced Glycation End products (AGEs) in hyperglycemia by administering 6-Nitrobenzimidazole derivatives. These derivatives were found to be effective not merely against the formation of AGE, but they can inhibit the action of AGEs at post-receptor levels.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.